JUM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gültekin, S.
Right arrow Articles by Araç, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gültekin, S.
Right arrow Articles by Araç, M.
© 2006 by the American Institute of Ultrasound in Medicine
J Ultrasound Med 25:1139-1145 • 0278-4297

The Role of Late-Phase Pulse Inversion Harmonic Imaging in the Detection of Occult Hepatic Metastases

Serap Gültekin, MD, Cem Yücel, MD, Hakan Özdemir, MD, Halil Çelik, MD, Suna Özhan Oktar, MD and Mehmet Araç, MD

Department of Radiology, Gazi University, School of Medicine, Besevler-Ankara, Turkey.

Address correspondence to Serap Gültekin, MD, Gazi Üniversitesi Tip Fakültesi, Radyoloji Anabilim Dali, 06510 Besevler-Ankara, Turkey. E-mail: serapgultekin{at}gazi.edu.tr

Objective. The purpose of this study was to investigate the efficacy of late-phase pulse inversion harmonic imaging (PIHI) in detecting occult metastases and to compare the results with helical computed tomography (CT) in a group of patients whose fundamental liver sonographic results were normal. Methods. Thirty-two patients (21 women and 11 men; age range, 20–87 years) with a known primary malignancy were enrolled in the study. The patients were evaluated with conventional sonography, unenhanced PIHI, and PIHI 3 minutes after the injection of Levovist (SH U 508A; Schering AG, Berlin, Germany). All patients also underwent triphasic helical CT within 1 week after sonography. In 1 patient, mangafodipir-enhanced magnetic resonance imaging was performed as part of the clinical workup. Results. After Levovist injection, in 4 (12.5%) of 32 patients, at least 1 hypoechoic lesion was detected by PIHI; multiple lesions were shown in 1 patient. The mean diameter of newly detected lesions was 12 mm. Triphasic helical CT also showed all of the lesions that were detected by PIHI. The diagnoses were confirmed by biopsy and CT findings in 2 patients and by the typical CT and magnetic resonance imaging findings in 1 patient. For the fourth patient, the diagnosis was confirmed by follow-up and CT. Conclusions. Late-phase PIHI is comparable to helical CT for detecting occult hepatic metastases, but it protects patients from the potentially hazardous effects of radiation and iodinated contrast agents. Further series involving a larger number of patients are needed to determine its place in the evaluation of cancer staging and treatment planning.

Key Words: contrast agent • harmonic imaging • occult hepatic metastases • pulse inversion • sonography

Abbreviations: CT, computed tomography • MI, mechanical index • Mn-DPDP, mangafodipir • MRI, magnetic resonance imaging • PIHI, pulse inversion harmonic imaging




This article has been cited by other articles:


Home page
J Ultrasound MedHome page
W. Luo, X. Zhou, X. Zheng, G. He, M. Yu, Q. Li, and Q. Liu
Role of Sonography for Implantation and Sequential Evaluation of a VX2 Rabbit Liver Tumor Model
J. Ultrasound Med., January 1, 2010; 29(1): 51 - 60.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
Y. Minami, H. Chung, M. Kudo, S. Kitai, S. Takahashi, T. Inoue, K. Ueshima, and H. Shiozaki
Radiofrequency Ablation of Hepatocellular Carcinoma: Value of Virtual CT Sonography with Magnetic Navigation
Am. J. Roentgenol., June 1, 2008; 190(6): W335 - W341.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Institute of Ultrasound in Medicine.